Stay updated on CTL019 in Adult ALL: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a Phase 2 study of CTL019 in adults with relapsed or refractory B-cell ALL, including its study details and eligibility criteria. The record indicates that the study was withdrawn and did not enroll participants.
    Difference
    35%
    Check dated 2026-11-07T15:08:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:46:20.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide notice announces the NIH transition from “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:11:02.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T14:55:18.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:08:44.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the detailed trial information with a generic error page. A minimal header/footer is displayed and a revision notice is shown indicating the page content is no longer accessible at this URL.
    Difference
    16%
    Check dated 2026-09-19T17:59:56.000Z thumbnail image

Stay in the know with updates to CTL019 in Adult ALL: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page.